BR0311146A - Uso de tibolona e de modulador de receptor de estrogênio seletivo, e, método e kit para o tratamento de um sintoma relacionado com a deficiência de estrogênio em um paciente do sexo feminino - Google Patents
Uso de tibolona e de modulador de receptor de estrogênio seletivo, e, método e kit para o tratamento de um sintoma relacionado com a deficiência de estrogênio em um paciente do sexo femininoInfo
- Publication number
- BR0311146A BR0311146A BR0311146-6A BR0311146A BR0311146A BR 0311146 A BR0311146 A BR 0311146A BR 0311146 A BR0311146 A BR 0311146A BR 0311146 A BR0311146 A BR 0311146A
- Authority
- BR
- Brazil
- Prior art keywords
- tibolone
- kit
- receptor modulator
- treating
- female patient
- Prior art date
Links
- 206010030247 Oestrogen deficiency Diseases 0.000 title abstract 4
- 208000024891 symptom Diseases 0.000 title abstract 4
- 229940095743 selective estrogen receptor modulator Drugs 0.000 title abstract 3
- 239000000333 selective estrogen receptor modulator Substances 0.000 title abstract 3
- WZDGZWOAQTVYBX-XOINTXKNSA-N tibolone Chemical compound C([C@@H]12)C[C@]3(C)[C@@](C#C)(O)CC[C@H]3[C@@H]1[C@H](C)CC1=C2CCC(=O)C1 WZDGZWOAQTVYBX-XOINTXKNSA-N 0.000 title abstract 3
- 229960001023 tibolone Drugs 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 206010006187 Breast cancer Diseases 0.000 abstract 2
- 208000026310 Breast neoplasm Diseases 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
"USO DE TIBOLONA E DE MODULADOR DE RECEPTOR DE ESTROGêNIO SELETIVO, E, MéTODO E KIT PARA O TRATAMENTO DE UM SINTOMA RELACIONADO COM A DEFICIêNCIA DE ESTROGêNIO EM UM PACIENTE DO SEXO FEMININO". A presente invenção provê um uso de tibolona e um SERM para a fabricação de um remédio para o tratamento de um sintoma relacionado com a deficiência de estrogênio para a prevenção de uma recorrência de câncer de mama em pacientes do sexo feminino sofrendo de, ou em risco de câncer de mama, que apresentam o sintoma relacionado com a deficiência de estrogênio.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02077050 | 2002-05-24 | ||
| PCT/EP2003/050178 WO2003099292A1 (en) | 2002-05-24 | 2003-05-20 | Treatment of post-menopausal complaints in breast cancer patients comprising tibolone and a serm |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0311146A true BR0311146A (pt) | 2005-03-15 |
Family
ID=29558370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0311146-6A BR0311146A (pt) | 2002-05-24 | 2003-05-20 | Uso de tibolona e de modulador de receptor de estrogênio seletivo, e, método e kit para o tratamento de um sintoma relacionado com a deficiência de estrogênio em um paciente do sexo feminino |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20050222100A1 (pt) |
| EP (1) | EP1511497A1 (pt) |
| JP (1) | JP2005531575A (pt) |
| KR (1) | KR20050005490A (pt) |
| CN (1) | CN1655796A (pt) |
| AR (1) | AR039843A1 (pt) |
| AU (1) | AU2003273170A1 (pt) |
| BR (1) | BR0311146A (pt) |
| CA (1) | CA2487268A1 (pt) |
| IL (1) | IL165129A0 (pt) |
| MX (1) | MXPA04011687A (pt) |
| PE (1) | PE20031047A1 (pt) |
| TW (1) | TW200307553A (pt) |
| WO (1) | WO2003099292A1 (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0862445B2 (en) * | 1995-10-06 | 2017-03-22 | Arch Development Corporation | Combination of herpes simplex virus and chemotherapy for treating cancer |
| WO2007143607A2 (en) | 2006-06-02 | 2007-12-13 | Pear Tree Women's Health Care | Method of treating atrophic vaginitis |
| US8933130B2 (en) | 2006-06-23 | 2015-01-13 | Radius Health, Inc. | Treatment of vasomotor symptoms with selective estrogen receptor modulators |
| WO2009137104A1 (en) * | 2008-05-09 | 2009-11-12 | Radius Health, Inc. | Combination therapy for breastcancer comprising an antiestrogenic agent |
| DE102008057230A1 (de) * | 2008-11-11 | 2010-05-12 | Bayer Schering Pharma Aktiengesellschaft | Synergistische pharmazeutische Kombination mit einem Estrogenrezeptorantagonisten und einem Progestin |
| ME02474B (me) | 2010-05-12 | 2017-02-20 | Radius Health Inc | Terapijski režimi |
| US9133182B2 (en) | 2010-09-28 | 2015-09-15 | Radius Health, Inc. | Selective androgen receptor modulators |
| ES2939940T3 (es) | 2014-03-28 | 2023-04-28 | Univ Duke | Tratamiento del cáncer de mama utilizando moduladores selectivos de los receptores de estrógenos |
| US9421264B2 (en) | 2014-03-28 | 2016-08-23 | Duke University | Method of treating cancer using selective estrogen receptor modulators |
| RU2737496C2 (ru) | 2015-04-29 | 2020-12-01 | Радиус Фармасьютикалз, Инк. | Способы лечения рака |
| JP7221699B2 (ja) | 2016-06-22 | 2023-02-14 | エリプセス ファーマ エルティーディー | Ａｒ＋乳癌の治療方法 |
| FI3565542T3 (fi) | 2017-01-05 | 2024-06-24 | Radius Pharmaceuticals Inc | Rad1901-2hcl:n polymorfisia muotoja |
| US11643385B2 (en) | 2018-07-04 | 2023-05-09 | Radius Pharmaceuticals, Inc. | Polymorphic forms of RAD1901-2HCl |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2342145C2 (ru) * | 2000-01-28 | 2008-12-27 | Андорешерш, Инк. | Селективные модуляторы рецептора эстрогена в комбинации с эстрогенами |
| US6756480B2 (en) * | 2000-04-27 | 2004-06-29 | Amgen Inc. | Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| HUP0401268A2 (hu) * | 2001-07-31 | 2004-11-29 | Pfizer Products Inc. | Ösztrogén agonisták/antagonisták, ösztrogének és progesztinek kombinációját tartalmazó gyógyszerkészítmények, valamint eljárás ezek előállítására |
-
2003
- 2003-05-16 TW TW092113384A patent/TW200307553A/zh unknown
- 2003-05-20 EP EP03740483A patent/EP1511497A1/en not_active Withdrawn
- 2003-05-20 MX MXPA04011687A patent/MXPA04011687A/es unknown
- 2003-05-20 PE PE2003000493A patent/PE20031047A1/es not_active Application Discontinuation
- 2003-05-20 WO PCT/EP2003/050178 patent/WO2003099292A1/en active Application Filing
- 2003-05-20 CN CNA038118041A patent/CN1655796A/zh active Pending
- 2003-05-20 AU AU2003273170A patent/AU2003273170A1/en not_active Abandoned
- 2003-05-20 US US10/515,712 patent/US20050222100A1/en not_active Abandoned
- 2003-05-20 JP JP2004506816A patent/JP2005531575A/ja active Pending
- 2003-05-20 KR KR10-2004-7018936A patent/KR20050005490A/ko not_active Application Discontinuation
- 2003-05-20 CA CA002487268A patent/CA2487268A1/en not_active Abandoned
- 2003-05-20 BR BR0311146-6A patent/BR0311146A/pt not_active IP Right Cessation
- 2003-05-22 AR ARP030101779A patent/AR039843A1/es not_active Application Discontinuation
-
2004
- 2004-11-09 IL IL16512904A patent/IL165129A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20050005490A (ko) | 2005-01-13 |
| MXPA04011687A (es) | 2005-03-31 |
| WO2003099292A1 (en) | 2003-12-04 |
| EP1511497A1 (en) | 2005-03-09 |
| CA2487268A1 (en) | 2003-12-04 |
| JP2005531575A (ja) | 2005-10-20 |
| US20050222100A1 (en) | 2005-10-06 |
| AR039843A1 (es) | 2005-03-02 |
| TW200307553A (en) | 2003-12-16 |
| CN1655796A (zh) | 2005-08-17 |
| AU2003273170A1 (en) | 2003-12-12 |
| PE20031047A1 (es) | 2003-12-23 |
| IL165129A0 (en) | 2005-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0311146A (pt) | Uso de tibolona e de modulador de receptor de estrogênio seletivo, e, método e kit para o tratamento de um sintoma relacionado com a deficiência de estrogênio em um paciente do sexo feminino | |
| NZ709704A (en) | Protein formulations and methods of making same | |
| BRPI0410503B8 (pt) | composição tópica e uso da composição | |
| SG148169A1 (en) | Combination drug therapy to treat obesity | |
| WO2008027912A3 (en) | Prediction of an agent's or agents' activity across different cells and tissue types | |
| WO2003087831A3 (en) | Proteins involved in breast cancer | |
| TW200642682A (en) | A combination of medical drugs to augment the anti-cancer effect of chemotherapy | |
| HK1069335A1 (en) | Use of anastrozole for the treatment of post-menopausal women having early breast cancer | |
| GB0124145D0 (en) | Genes and proteins for prevention,prediction,prognosis and therapy of cardiovascular disease | |
| MXPA04004306A (es) | Uso de antagonistas del receptor de endotelina para el tratamiento de enfermedades tumorales. | |
| WO2007081486A3 (en) | Oral administration of defensins to treat intestinal diseases | |
| ATE318328T1 (de) | Diagnostika und therapeutika für osteoporose | |
| MX2024004899A (es) | Compuestos de piperidinilpirazina-carboxamida para tratar y prevenir el cancer y para degradar btk. | |
| GB0020504D0 (en) | Therapeutic method | |
| MXPA02009744A (es) | Uso de fulvestrant en el tratamiento de cancer resistente de mama. | |
| GB0405349D0 (en) | Cancer therapy and medicaments therefor | |
| BR0313081A (pt) | Combinação de um inibidor de aromatase com um bisfosfanato | |
| BR0312929A (pt) | Uso de um composto, e, métodos de tratamento, prevenção ou alìvio de uma doença, distúrbio ou condição de um corpo de animal vivo, e da degeneração macular relacionada com a idade de um corpo de animal vivo | |
| IS2488B (is) | Fyrirbygging á krabbameini í ristli og endaþarmi | |
| SI1596879T1 (sl) | Uporaba spojine kahalalida za pripravo zdravila za zdravljenje luskavice | |
| PL367707A1 (en) | Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol | |
| BR0309808A (pt) | Combinação para o tratamento de distúrbios das vias aéreas | |
| RS37804A (en) | Use of n,n-diethyl-2-/-4-(phenylmethyl)- phenoxy/ethanamine monohydrochloride (dppe)in cancer therapy | |
| MXPA05013975A (es) | Tratamiento de enfermedades asociadas con amiloide y epileptogenesis. | |
| WO2003020294A8 (de) | Markierung der aromatase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: N.V. ORGANON (NL) Free format text: TRANSFERIDO DE: AKZO NOBEL N.V. |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2051 DE 27/04/2010. |